Stephen KennedyHead of Technical Operations at CRISPR TherapeuticsSpeaker
Agenda Sessions
Keynote Panel Discussion: Big Pharma’s CGT Playbook - Top Investment Priorities and Emerging Opportunities
, 2:05pmView Session